As of 2024-12-13, the Relative Valuation of Moderna Inc (MRNA) is (89.44) USD. This relative valuation is based on P/E multiples. With the latest stock price at 42.82 USD, the upside of Moderna Inc based on Relative Valuation is -308.9%.
The range of the Relative Valuation is (83.80) - (89.58) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.5x - 15.5x | 15.0x |
| Forward P/E multiples | 14.5x - 17.4x | 16.0x |
| Fair Price | (83.80) - (89.58) | (89.44) |
| Upside | -295.7% - -309.2% | -308.9% |
| Date | P/E |
| 2024-12-11 | -7.42 |
| 2024-12-10 | -7.18 |
| 2024-12-09 | -7.90 |
| 2024-12-06 | -7.69 |
| 2024-12-05 | -7.43 |
| 2024-12-04 | -7.20 |
| 2024-12-03 | -7.37 |
| 2024-12-02 | -7.66 |
| 2024-11-29 | -7.45 |
| 2024-11-27 | -7.51 |
| 2024-11-26 | -7.28 |
| 2024-11-25 | -7.55 |
| 2024-11-22 | -7.11 |
| 2024-11-21 | -6.62 |
| 2024-11-20 | -6.39 |
| 2024-11-19 | -6.45 |
| 2024-11-18 | -6.84 |
| 2024-11-15 | -6.38 |
| 2024-11-14 | -6.88 |
| 2024-11-13 | -7.29 |
| 2024-11-12 | -7.52 |
| 2024-11-11 | -7.40 |
| 2024-11-08 | -8.10 |
| 2024-11-07 | -8.70 |
| 2024-11-06 | -8.96 |
| 2024-11-05 | -9.22 |
| 2024-11-04 | -9.26 |
| 2024-11-01 | -9.45 |
| 2024-10-31 | -9.41 |
| 2024-10-30 | -9.47 |
| 2024-10-29 | -9.55 |
| 2024-10-28 | -9.48 |
| 2024-10-25 | -9.19 |
| 2024-10-24 | -9.14 |
| 2024-10-23 | -9.24 |
| 2024-10-22 | -9.24 |
| 2024-10-21 | -9.31 |
| 2024-10-18 | -9.36 |
| 2024-10-17 | -9.49 |
| 2024-10-16 | -9.94 |
| 2024-10-15 | -9.92 |
| 2024-10-14 | -9.99 |
| 2024-10-11 | -10.09 |
| 2024-10-10 | -9.83 |
| 2024-10-09 | -10.18 |
| 2024-10-08 | -10.10 |
| 2024-10-07 | -10.16 |
| 2024-10-04 | -10.42 |
| 2024-10-03 | -10.57 |
| 2024-10-02 | -10.93 |